Progenics Pharma (PGNX)

5.29 -0.10 (1.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/18 *Est.)

Latest Headlines

Form 8-K PROGENICS PHARMACEUTICAL For: Nov 08 November 15, 2019 4:52 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 13, 2019 6:02 AM - SEC Filing Form SC 13D/A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 12, 2019 1:48 PM - SEC Filing Progenics Pharma (PGNX) CEO Mark. R. Baker Resigns November 12, 2019 6:26 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Nov 11 November 12, 2019 6:08 AM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL November 8, 2019 5:22 PM - SEC Filing Progenics Pharmaceuticals Announces Delivery of Consents and Revocations to Independent Inspector of Elections November 8, 2019 4:05 PM - Globe NewsWire Progenics Pharmaceuticals Announces Delivery of Consents and Revocations to Independent Inspector of Elections November 8, 2019 4:05 PM - StreetInsider Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 8, 2019 3:53 PM - SEC Filing Velan Receives Requisite Number of Written Consents to Reconstitute Majority of Progenics Board November 8, 2019 2:21 PM - BizWire Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 7, 2019 5:07 PM - SEC Filing Form 10-Q PROGENICS PHARMACEUTICAL For: Sep 30 November 7, 2019 4:12 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 7, 2019 10:09 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 7, 2019 8:31 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Nov 07 November 7, 2019 8:16 AM - SEC Filing Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results November 7, 2019 8:01 AM - Globe NewsWire Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results November 7, 2019 8:00 AM - StreetInsider Form DEFA14A PROGENICS PHARMACEUTICAL November 6, 2019 5:08 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 6, 2019 5:07 PM - SEC Filing Progenics Reminds Shareholders that November 17 is the True Deadline for Velan’s Consent Solicitation November 6, 2019 8:01 AM - Globe NewsWire Progenics Reminds Shareholders that November 17 is the True Deadline for Velan’s Consent Solicitation November 6, 2019 8:00 AM - StreetInsider Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 5, 2019 4:47 PM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL November 5, 2019 9:16 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 5, 2019 9:13 AM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. November 4, 2019 11:11 AM - SEC Filing Progenics Urges Shareholders to Reject the Risk and Uncertainty That Would be Caused by Giving Velan’s Nominees Control of the Board November 4, 2019 8:00 AM - Globe NewsWire Glass Lewis Recommends Stockholders Vote on GREEN Consent Card for Velan Nominees to Constitute Majority of Progenics Board November 4, 2019 8:00 AM - BizWire Progenics Urges Shareholders to Reject the Risk and Uncertainty That Would be Caused by Giving Velan’s Nominees Control of the Board November 4, 2019 8:00 AM - StreetInsider Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 1, 2019 5:12 PM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Oct 31 November 1, 2019 5:10 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC November 1, 2019 5:08 PM - SEC Filing Progenics Reminds Shareholders that November 17 is the Only Deadline for Velan’s Consent Solicitation November 1, 2019 1:00 PM - Globe NewsWire Progenics Reminds Shareholders that November 17 is the Only Deadline for Velan’s Consent Solicitation November 1, 2019 1:00 PM - StreetInsider Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. November 1, 2019 9:03 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Oct 29 October 30, 2019 6:23 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 30, 2019 6:15 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 28, 2019 5:11 PM - SEC Filing Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors October 28, 2019 2:01 PM - StreetInsider Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors October 28, 2019 2:00 PM - Globe NewsWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 28, 2019 10:50 AM - SEC Filing ISS Recommends Shareholders Vote on the GREEN Consent Card for Election of Velan Nominees and Removal of Progenics CEO October 28, 2019 7:00 AM - BizWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 24, 2019 3:04 PM - SEC Filing Independent Director Candidates Nominated by Velan Issue Letter to Progenics Shareholders October 24, 2019 2:05 PM - BizWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 23, 2019 5:12 PM - SEC Filing Velan Responds to Misleading Communications from Progenics October 23, 2019 5:03 PM - BizWire Form 8-K PROGENICS PHARMACEUTICAL For: Oct 23 October 23, 2019 4:31 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 23, 2019 4:29 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 23, 2019 4:23 PM - SEC Filing Progenics Highlights Additional Serious Concerns About Velan Capital, L.P. October 23, 2019 9:56 AM - StreetInsider Progenics Highlights Additional Serious Concerns About Velan Capital, L.P. October 23, 2019 9:55 AM - Globe NewsWire Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 23, 2019 9:02 AM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 22, 2019 11:33 AM - SEC Filing Velan Sends Letter to Progenics Stockholders October 22, 2019 9:00 AM - BizWire Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 22, 2019 6:03 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Oct 21 October 22, 2019 6:02 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 21, 2019 5:05 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 21, 2019 12:07 PM - SEC Filing Progenics Sends Letter to Shareholders October 21, 2019 8:47 AM - StreetInsider Progenics Sends Letter to Shareholders October 21, 2019 8:45 AM - Globe NewsWire Velan Issues Presentation Outlining Nominees’ Comprehensive Strategic Plan to Save Progenics October 21, 2019 8:00 AM - BizWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 21, 2019 6:02 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Oct 11 October 18, 2019 5:05 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 16, 2019 12:47 PM - SEC Filing Form DFRN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 11, 2019 4:03 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 10, 2019 6:02 AM - SEC Filing Progenics Pharma (PGNX) Sends Letter to Shareholders October 9, 2019 4:34 PM - StreetInsider Progenics Sends Letter to Shareholders October 9, 2019 4:31 PM - StreetInsider Progenics Sends Letter to Shareholders October 9, 2019 4:30 PM - Globe NewsWire Form DEFC14A PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 8, 2019 4:26 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 8, 2019 11:15 AM - SEC Filing Velan Sends Letter to Progenics Pharmaceuticals (PGNX) Stockholders October 8, 2019 8:02 AM - StreetInsider Velan Sends Letter to Progenics Pharmaceuticals Stockholders and Files Definitive Consent Statement October 8, 2019 8:00 AM - BizWire Form DEFC14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 8, 2019 6:02 AM - SEC Filing Form PRER14A PROGENICS PHARMACEUTICAL October 4, 2019 5:22 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 4, 2019 5:08 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 4, 2019 5:05 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 3, 2019 6:06 AM - SEC Filing Form PRRN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 3, 2019 6:06 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 2, 2019 5:22 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 2, 2019 5:19 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 2, 2019 5:18 PM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 2, 2019 4:45 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. October 2, 2019 2:37 PM - SEC Filing Velan Comments on Announced Sale of Progenics to Lantheus October 2, 2019 1:23 PM - BizWire Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 2, 2019 9:24 AM - SEC Filing Pre-Open Movers 10/02: (VHC) (AIMT) (LEN) Higher; (SVRA) (UNFI) (AYI) Lower (more...) October 2, 2019 9:19 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Oct 01 October 2, 2019 7:43 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC October 2, 2019 7:41 AM - SEC Filing Form 425 PROGENICS PHARMACEUTICAL Filed by: Lantheus Holdings, Inc. October 2, 2019 7:29 AM - SEC Filing Progenics Pharma (PGNX) to Resume Trading at 7:40 am October 2, 2019 7:13 AM - StreetInsider Lantheus (LNTH) to Acquire Progenics (PGNX) in All-Stock Transaction October 2, 2019 7:09 AM - StreetInsider Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company October 2, 2019 7:08 AM - BizWire Progenics Pharma (PGNX) Halted, News Pending October 2, 2019 7:03 AM - StreetInsider Form PRRN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. September 30, 2019 5:24 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Sep 18 Filed by: MacDougall Ann L. September 27, 2019 5:24 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Sep 18 Filed by: Mims David W. September 27, 2019 5:21 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Sep 18 Filed by: Maeusli Heinz Christoph September 27, 2019 5:19 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Sep 18 Filed by: Ende Eric J September 27, 2019 5:16 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Sep 18 Filed by: Ber Gerard September 27, 2019 5:14 PM - SEC Filing Form PREC14A PROGENICS PHARMACEUTICAL Filed by: PROGENICS PHARMACEUTICALS INC September 25, 2019 10:22 AM - SEC Filing Form SC 13D/A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. September 19, 2019 5:23 PM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL September 19, 2019 6:02 AM - SEC Filing Progenics Confirms Notice of Preliminary Consent Solicitation by Velan Capital, L.P. Despite Repeated Efforts by the Company to Reach a Reasonable Resolution September 18, 2019 5:00 PM - StreetInsider Progenics Confirms Notice of Preliminary Consent Solicitation by Velan Capital, L.P. Despite Repeated Efforts by the Company to Reach a Reasonable Resolution September 18, 2019 4:59 PM - Globe NewsWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. September 18, 2019 3:31 PM - SEC Filing Velan Launches Consent Solicitation to Reconstitute the Progenics Board With Its Five Highly-Qualified, Independent Director Nominees September 18, 2019 8:55 AM - BizWire Form PREC14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. September 18, 2019 8:35 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Sep 09 Filed by: Altiva Management Inc. September 11, 2019 1:33 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Sep 05 Filed by: LTE Management, LLC September 9, 2019 6:14 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Sep 03 Filed by: Altiva Management Inc. September 5, 2019 4:38 PM - SEC Filing Progenics Pharmaceuticals Announces Presentation at the International Conference on Immunotherapy Radiotherapy Combinations September 3, 2019 8:31 AM - StreetInsider Progenics Pharmaceuticals Announces Presentation at the International Conference on Immunotherapy Radiotherapy Combinations September 3, 2019 8:30 AM - Globe NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Aug 27 August 28, 2019 6:01 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Aug 23 Filed by: Altiva Management Inc. August 27, 2019 3:46 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Altiva Management Inc. August 27, 2019 3:42 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Nohria Virinder August 27, 2019 3:40 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: LTE Management, LLC August 27, 2019 3:37 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Sarpangal Deepak August 27, 2019 3:29 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Cooke Terence August 27, 2019 3:25 PM - SEC Filing Form SC 13D/A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. August 26, 2019 5:03 PM - SEC Filing Full Article List